Niche GI Focus The company specializes in GI microbiome science and has a history of launching GI-related products such as BiomeBliss and a microbiome modulator, indicating a strong potential for partnerships in pet and human wellness markets and subscription-based nutritional supplements.

Pet Market Fit Recent partnership with PetGiftz to market a dog dietary supplement suggests readiness for channel expansion in the pet wellness space, presenting opportunities for co-branded campaigns, retailer programs, and cross-sell of microbiome-based pet products.

Early Stage Funding With a Series B completed in 2017 and current revenue under one million, there may be appetite among investors or grant programs for scaled commercialization efforts; potential for strategic finance to accelerate product launches and sales reach.

Growth Levers History of product launches (BiomeBliss; microbiome modulator) shows ability to bring first-in-class offerings to market, signaling opportunities to expand into additional GI health categories, human dietary supplements, or veterinary solutions.

Low Headcount Small team (11-50 employees) implies agility but limited sales capacity; opportunity to provide scalable marketing and sales support, channel partnerships, and outsourcing arrangements to accelerate regional and online funnel development.